Applications Being Progressed Archives

COVID-19

Firstkind is evaluating the use of the geko™ device for blood clot prevention in COVID-19 patients.
Find out more× Read more

Venous Stenting

Firstkind is evaluating use of the geko™ device to improve inflow of blood through newly implanted lower limb venous stents to reduce the risk of stent occlusion.× Read more

Kidney Transplant

Firstkind is evaluating the use of the geko™ device to increase blood flow and reduce post-operative edema following kidney transplant to accelerate patient recovery. As part of the research, two RCT’s have been published: ‘The geko™ device impact on incisional wound healing in kidney-pancreas transplant patients.'
Find out more
and ‘The use of the geko™ to reduce hospitalization and improve graft function post- transplantation.'
Find out more× Read more

Total Knee Replacement (TKR)

Firstkind is evaluating use of the geko™ device to reduce the very common issue of post-operative oedema in TKR, and to accelerate patient recovery. × Read more

Total Hip Replacement (THR)

Firstkind has published evidence reporting the geko^™ device reduces the build-up of post-operative oedema in THR Find out more. Further research into this clinical application area is being progressed.× Read more

Anterior Cruciate Ligament (ACL)

Firstkind is evaluating use of the geko™ device to reduce the very common issue of post-operative oedema in ACL injury, and to accelerate patient recovery.× Read more

Partner with us

If you’re interested in becoming an international distribution partner, get in touch.

Find out more

News

Al Mahmoud Medical Center, Qatar, adopts the geko™ device for prevention of venous thromboembolism (VTE) and reduction of edema (swelling)

Blog

The geko™ device receives UK Conformity Assessed Mark

Social Media

Follow our social media channels to read our latest updates

Find out more